Table 4.
Participants’ predicted 5-year survival rates compared with actual rates
| Sex | Site | Predicted rate by participants |
Actual survival rate (%)a) | No. (%) |
|||
|---|---|---|---|---|---|---|---|
| Median (IQR) | Mean±SD | Underestimation | Accurate estimation | Overestimation | |||
| Men | Total | 50 (30-67) | 48.4±21.8 | 57.6 | 556 (56.1) | 170 (17.2) | 265 (26.7) |
| Stomach | 50 (30-70) | 48.2±20.7 | 70.1 | 742 (74.9) | 148 (14.9) | 101 (10.2) | |
| Lung | 30 (20-50) | 35.9±20.8 | 18.3 | 159 (16.0) | 185 (18. 7) | 647 (65.3) | |
| Liver | 35 (20-50) | 37.4±20.4 | 28.5 | 311 (31.4) | 182 (18.4) | 498 (50.3) | |
| Colon, rectum | 40 (20-50) | 39.7±21.1 | 75.8 | 930 (93.8) | 47 (4.7) | 14 (1.4) | |
| Prostate | 50 (30-70) | 52.0±23.1 | 92.0 | 918 (92.6) | 70 (7.1) | 3 (0.3) | |
| Women | Total | 50 (30-70) | 49.8±22.2 | 75.2 | 883 (87.5) | 107 (10.6) | 19 (1.9) |
| Stomach | 50 (30-70) | 49.9±20.4 | 67.9 | 731 (72.5) | 155 (15.4) | 123 (12.2) | |
| Lung | 30 (20-50) | 36.5±21.5 | 26.8 | 368 (36.5) | 148 (14.7) | 493 (48.9) | |
| Liver | 40 (20-50) | 37.6±21.0 | 28.7 | 319 (31.6) | 174 (17.2) | 516 (51.1) | |
| Colon, rectum | 40 (20-60) | 40.5±21.8 | 70.7 | 861 (85.3) | 82 (8.1) | 66 (6.5) | |
| Breast | 60 (40-70) | 56.6±21.8 | 91.3 | 934 (92.6) | 64 (6.3) | 11 (1.1) | |
| Uterine cervix | 60 (40-70) | 56.3±22.0 | 80.1 | 777 (77.0) | 149 (14.8) | 83 (8.2) | |
| Thyroid | 70 (50-80) | 65.5±23.1 | 99.9 | 935 (92.7) | 38 (3.8) | 36 (3.6) | |
IQR, interquartile range; SD, standard deviation.
a)
5-year survival rate for each cancer based on population-based cancer registry in South Korea between 2007-2011.